UroGen Pharma URGN Finance Lease Liabilities (Total)
Finance Lease Liabilities (Total) at other companies
Other financials
Where this comes from
Reported directly by UroGen Pharma in its filing.
Tagged under the XBRL concept us-gaap:FinanceLeaseLiability.
The official record: UroGen Pharma’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about UroGen Pharma's finance lease liabilities (total).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is UroGen Pharma's finance lease liabilities (total)?
- UroGen Pharma (URGN) reported finance lease liabilities (total) of $4.49M in Q1 2026.
- How has UroGen Pharma's finance lease liabilities (total) changed year-over-year?
- UroGen Pharma's finance lease liabilities (total) increased by 24.1% year-over-year, from $3.62M to $4.49M.
- What does finance lease liabilities (total) mean?
- Finance lease liabilities (total) represent the aggregate present value of all future lease payments for assets where the company assumes substantially all risks and rewards of ownership. This metric reflects the long-term debt-like burden associated with financing infrastructure or equipment through leases. It is a key component of the company's total leverage profile.